Biodesix, Inc.
BDSX
$16.66
$1.449.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.93% | 17.86% | 9.77% | 7.71% | 14.11% |
| Total Depreciation and Amortization | -2.55% | -1.78% | 1.83% | 8.20% | 7.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.34% | -41.15% | -37.48% | -44.15% | -34.42% |
| Change in Net Operating Assets | 72.78% | 101.54% | 97.07% | 93.21% | -1,118.90% |
| Cash from Operations | 40.78% | 52.17% | 50.48% | 40.13% | -37.53% |
| Capital Expenditure | 91.34% | 91.98% | 81.17% | 89.12% | 80.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.46% | 31.43% | 6.04% | -23.21% | -53.95% |
| Cash from Investing | 87.59% | 88.28% | 78.71% | 87.43% | 78.86% |
| Total Debt Issued | -- | -- | 0.00% | 0.00% | -- |
| Total Debt Repaid | 57.78% | 58.82% | 43.14% | 24.00% | 10.00% |
| Issuance of Common Stock | -54.97% | -86.11% | -92.03% | -99.20% | 89.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.05% | 66.96% | 81.30% | 90.46% | 38.49% |
| Cash from Financing | -35.32% | -68.46% | -80.36% | -88.54% | 58.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.40% | -18,507.69% | -227.97% | -186.62% | 144.34% |